Jim Cramer's Mad Money Review

This site is dedicated towards tracking Jim Cramer's stock picks on his TV show Mad Money. Read about and discuss Jim Cramer's ability to move markets. Be ahead of the stock market. Get the news before its news.

Tuesday, October 14, 2008

Johnson & Johnson (JNJ) Beats the Street

The New Brunswick, N.J.-based maker of contraceptives, baby care items, medical devices and prescription drugs reported net income of $3.31 billion, or $1.17 per share, up from $2.55 billion, or 88 cents per share, in the year-ago period.
Revenue climbed 6.3 percent, to $15.9 billion from $14.97 billion.
Analysts surveyed by Thomson Financial expected earnings per share of $1.11 and revenue of $15.69 billion.

Labels: ,

Monday, November 19, 2007

Jim Cramer's Mad Money Stock Recap Nov. 16th

On Friday Cramer bagan by talking about a recommendation he made on Thursday in the Lightning Round that he wants to correct. He had said that St. Jude Medical (STJ) was a sell, and after giving it some thought, he realized that it should be a buy. His reasons were that Medtronic (MDT) had a recall in a market where these two companies are the only players, health care stocks are good defensive plays, and it is trading at just over 1X its growth rate.Then Cramer went to the phonelines. The first caller asked about Johnson & Johnson (JNJ), and Cramer said that it is a safe play in a slowing economy, plus Warren Buffet is buying shares. Second caller asked about Humana (HUM), and Cramer said that he doesn't know why the analysts don't like the stock, and that it is a cheap stock. He also said that he likes UnitedHealth (UNH) better, partially because Warren Buffet is buying this as well. Another caller asked about Hansen Medical (HNSN), and Cramer said that he thinks it has run its course and he doesn't want anything to do with it. The last caller asked about Beijing Medical (BJGP), and Cramer said that he won't recommend this Chinese stock since they are so risky.Cramer came back and talked to (CSX) CEO Michael Ward who talked about their stock buyback, upcoming earnings, and why a hedge fund has been asking for a change in leadership. Cramer concluded that this stock is a buy.In Cramer's "Game Plan" for next week, he said that he won't be recommending any individual stocks because the big investors are unsure right now, so they are unpredictable. Cramer said that Wells Fargo (WFC) gave a very negative report on the housing market and they are one of the best banking stocks out there, so the bad banking stocks must be really suffering. He said to get out of Countrywide (CFC), Washington Mutual (WM), Downey Financial (DSL), E*Trade (ETFC), Standard Pacific (SPF), Pulte Homes (PHM), Centex (CTX), and Beazer (BZH), and buy defensive stocks like Coca-Cola (KO), Altria (MO), Colgate (CL), Clorox (CLX), Avon (AVP), and Medco Health (MHS). Cramer said that things have gotten much worse for the economy recently, and the Fed can't let the economy fall apart, so they will have to take action soon.Cramer went over his mining picks that have been doing well: BHP Billiton (BHP), C.V.R.D. (RIO), and Freeport McMoran (FCX), and then talked with the CEO of one that hasn't: Lundin Mining (LMC). It is down since they didn't have a very good quarter and he wants to know whether it is time to give up on the stock or buy more. The CEO was optimistic, but Cramer said that he wants you to wait until they report another quarter before buying more.Lastly, Cramer did a review of the week and ended the show.

Labels: , , , , , , , , , , ,

Friday, June 08, 2007

Jim Cramer's Mad Money Stock Recap June 7th

A Reliab-Oil Stock: XTO Energy (NYSE: XTO - News)
Cramer says he has finally found the "perfect" oil company which takes advantage of high oil prices by exploiting new properties rather than just buying back stock. XTO has risen 14% since Cramer recommended it in March, and with its recent acquisition of Dominion Resources, it should see double-digit growth for four or five years, according to Cramer.
Interview with Duncan Niederauer, president and co-COO of NYSE Euronext (NYSE: NYX - News)
Cramer's growth stock for 2007, NYX, is down 15%, but he is not backing away. While Euronext is growing rapidly, Cramer admits NYX is turning into the "worst performing" stock he's seen. Duncan Niederauer commented NYX is the only multi-product exchange; "It's still a wonderfully scaleable business, and a lot of the market doesn't know how to evaluate us because we're not quite as attractive as the derivative-only exchanges," he told Cramer. However, he added that NYX is still more attractive than the equity-only exchanges. Concerning derivatives, Niederauer said, "The U.S. futures market is still a hole in our global footprint .... The only way in is an acquisition." Cramer commented on how rapidly NYX drops, and Niederauer conceded NYX "trades in a very choppy way for a large-cap company." Although he can't predict when NYX will start moving up, Cramer says he is sticking with NYX.
Sell Block: Norfolk Southern (NYSE: NSC - News), Johnson & Johnson (NYSE: JNJ - News), Guess? (NYSE: GES - News), Monster Worldwide (NasdaqGS: MNST - News)
While Cramer's predictions of NSC 's and JNJ 's declines were fulfilled, and GES jumped as he expected, Cramer admitted he missed "the big one" of the week, namely, the selloff and vitality in the bond market. The lesson from this error is "You ignore what the big institutional investors are doing at your own peril," Cramer said, and added investors should not overlook the bond market. Cramer is still hopeful that MNST will win a bid and believes the new CFO,Timothy Yates, will make moves toward selling the company.
Mad Mail: Wal-Mart (NYSE: WMT - News), Target (NYSE: TGT - News), Lowes (NYSE: LOW - News), Verizon (NYSE: VZ - News)
Cramer says WMT's risk reward is superior to TGT's, which should be sold because it has increased substantially. Since WMT is not currently buildng new stores, the company can buy back stock and revamp its existing stores. Cramer adds he also likes LOW. He told another viewer Verizon has a solid yield and increasing growth. Concerning what action to take in the decline, Cramer coached his viewers; "Let it come in -- let the market open down ... If it opens up, do some selling. Don't do any buying. I'll tell you when I think it's overdone."
Published by SeekingAlpha

Labels: , , , , , , , , , , ,

Friday, May 25, 2007

Jim Cramer's Mad Money Stock Recap May 24

Six More Dow Stocks: International Business Machines (NYSE: IBM - News), Johnson & Johnson (NYSE: JNJ - News), J.P Morgan Chase (NYSE: JPM - News), McDonald's (NYSE: MCD - News), Merck Co. (NYSE: MRK - News), Microsoft (NasdaqGS: MSFT - News)
Cramer continued his series on Dow Stocks by admitting his target of $110 for IBM was too conservative, and given the company's great dividend and buyback, it should reach $114, but no higher. JNJ is a sell in spite of Warren Buffet's buying the stock. Cramer thinks it is staying at $63, and opines that maybe Warren Buffet liked the steady nature of the band-aid business, but adds "With so many other great names in the Dow, why back up the truck for band-aids?" Cramer called JPM's CEO Jamie Dimond a "great banker," but thinks he is going to be prevented from bringing out the best in JPM by the Fed; "Three more points for JPM, and then I'd declare victory." While MCD has a great international business, Cramer thinks it will peak 4 points from now at $55. Cramer says he was too conservative predicting MRK would go to $50, but at $53, he says the stock is "pretty much done for the year." On the other hand, he admits he was too bullish on MSFT, but is not changing his $35 target, since the company may underpromise and overdeliver.
Google (NasdaqGS: GOOG - News) and Amazon (NasdaqGS: AMZN - News)
Google has been stalled for a while, but Amazon has brought "in the jumper cables," says Cramer. AMZN's move from $39 to $69 makes GOOG look cheap in comparison, especially since Google has 63% sales growth and almost no competition while AMZN has 33% growth with competition from almost every retailer in America. Cramer sets the target for Google at $600, but admits he is being conservative.
Sell Block: CA Inc. (NYSE: CA - News), Analog Devices (NYSE: ADI - News)
Cramer declared a special "Crime and Punishment" edition of this week's Sell Block, inspired by the crime of his "hubris" (overweening pride) last week when he broke his own rule about avoiding tech until August. He now regrets having recommended CA which is down 7.4% since last Friday and ADI which he "missed by a mile."
Mad Mail: MEMC Electronic Materials (NYSE: WFR - News), Taser International Inc. (NasdaqGS: TASR - News), Rowan Companies Inc (NYSE: RDC - News), National Oilwell Varco (NYSE: NOV - News)
When a viewer asked how to play the shortage of polysilicon in Chinese Solar IPOs, Cramer said WFR is the obvious choice, but it missed the quarter and at $58, it's a "no-go." Cramer told another viewer to hold on to Taser, which he recommended ahead of the French election, for at least a few more points. Cramer says RDC has "too much actual drill for me" and says NOV is still "best in show."

Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , ,

Monday, May 14, 2007

Jim Cramer's Mad Money Review May 11th

Time Heals all Wounds: Kinetic Concepts (NYSE: KCI - News) and Smith & Nephew (NYSE: SNN - News)
Although Cramer usually prefers medical stocks which are a "pastiche," he likes KCI as a speculative stock even though it is levered only to wound-care and therapeutic service products. He is not concerned about the "nasty beating" KCI has taken, since the bulls and bears tend to fight it out over companies like KCI, and Cramer thinks the bulls will win. Another concern is KCI has reached 90% saturation in wound care and now has to compete for market share with SNN which recently acquired Blue Sky Medical. Cramer believes KCI has many competitive advantages, its 3% drop was "overdone," and only 10% of its revenue comes from bandages. He is confident KCI will bounce back.
On the Mend: Micrus Endovascular (NasdaqGM: MEND), Boston Scientific (NYSE: BSX - News) and Johnson & Johnson (NYSE: JNJ - News)
While those holding the stock may be in the "House of Pain" after MEND failed to get approval in China for its cerebral aneurysm treatment, Cramer thinks its $2 fall is a good opportunity to buy. He believes approval has been postponed and not cancelled, and would sell into strength once the treatment is approved. Cramer is not worried about large competitors BSX and JNJ. He also notes MEND could be a takeover target; "It either makes you money or it will get bought out." Cramer would buy the stock in increments andwould use limit orders.
Game Plan for the Coming Week: Thermo Fisher Scientific (NYSE: TMO - News), J.C. Penney (NYSE: JCP - News), Kohl's (NYSE: KSS - News), Home Depot (NYSE: HD - News), TJX Companies (NYSE: TJX - News), Jack in the Box (NYSE: JBX - News), Deere (NYSE: DE - News)
Cramer would look into buying scientific-instruments producer TMO before its analyst meeting on Tuesday. He also likes retailers JCP, KSS which report Thursday, and he thinks the downside has been priced into the stocks. Cramer is currently bullish on retail, and would buy half a position in HD before its Tuesday report, since he believes its management is developing "retail-savvy." Tuesday is also the day Cramer believes investors will see a "terrific" report from TJX and a "gigantic beat" from JBX, and he would buy ahead. However, Cramer would wait until after DE's report on Wednesday before buying, because the stock has increased, and he would wait for a selloff and a price drop.
CEO Interview: Mark Shapiro, Six Flags (NYSE: SIX - News)
Mark Shapiro is looking forward to an "extremely good summer season" given the number of group sales and season passes SIX has already sold. Meanwhile, the company has been investing in more aggressive marketing, employee training and recruiting. Although the weather is an unknown variable, Shapiro's aim is to "increase value proposition for our guests." Cramer remarks Shapiro is "good to go" and is sticking with Six Flags.
Published By SeekingAlpha

Labels: , , , , , , , , , , , , ,

Thursday, April 12, 2007

Jim Cramer's Stop Trading April 11

Johnson & Johnson (NYSE: JNJ - News), Goldman Sachs (NYSE: GS - News): It is time to do some spring cleaning in portfolios ahead of earnings season when it is difficult to make money, said Cramer. He would trim positions that are too fat and would get rid of stocks that aren't working. Cramer sold JNJ ahead of what he predicts will be a bad quarter, but would not get rid of any GS, which sells at an 8 x earnings.
Akamai (NasdaqGS: AKAM): Cramer calls AKAM a "favored nation tech stock" which he would buy even ahead of the difficult earnings season. He likes the business model and is always a "go-to name on weakness."
World Wrestling Entertainment Inc. (NYSE: WWE - News): As an international growth story, Cramer likes WWE and has faith in its CEO Vince McMahon. He predicts the stock has two or three more points to the upside, and likes its yield.
Published by SeekingAlpha

Labels: , , , , ,

Wednesday, April 11, 2007

Hot Stocks to Watch for Today

Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
PalmOne (NasdaqGS:PALM - News). PALM's PowerRating is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Vanda Pharmaceuticals (NasdaqGM:VNDA - News). VNDA's PowerRating is 7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Safeco (NYSE:SAF - News) & Northstar Realty Finance (NYSE:NRF - News). SAF's PowerRating is 7, and NRF's PowerRating is 6.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
LHC Group (NasdaqGM:LHCG - News). LHCG's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Johnson & Johnson (NYSE:JNJ - News). JNJ's PowerRating is 4.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
NutriSystem (NasdaqGS:NTRI - News). NTRI's PowerRating is 1.
PowerRatings are courtesy of PowerRatings.net

Labels: , , , , , , ,

Thursday, March 29, 2007

Hot Options to Watch Today

Most Under Priced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
Google Jun 510 Calls (NasdaqGS:GOOG - News) . GOOG's PowerRating is 5.
Most Under Priced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
Sandisk Apr 45 Puts (NasdaqGS:SNDK - News). SNDK's PowerRating is 6.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
Intuitive Surgical Apr 135 Calls (NasdaqGS:ISRG - News). ISRG's PowerRating is 4.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
MGIC Investment Corp. June 50 Puts (NYSE:MTG - News). MTG's PowerRating is 5.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
None Today
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock.
None Today
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
Johnson & Johnson (NYSE:JNJ - News). JNJ's PowerRating is 5. Halliburton (NYSE:HAL - News). HAL's PowerRating is 4. Amgen (NasdaqGS:AMGN - News). AMGN's PowerRating is 6. PowerRatings are courtesy of TradingMarkets.com

Labels: , , , , , , ,

Friday, March 16, 2007

Jim Cramer's Mad Money Review Mar. 15

A Second Look at Cigna (NYSE: CI - News)
Although Cramer has not liked Cigna in the past, he is taking another look at the non-pharma health care company because of its serious buyback plan. "Nothing is more reassuring than a company that believes in itself," said Cramer, noting that Cigna bought back 20% of the company since 2004 and is shrinking its number of shares so rapidly, it is "practically going private." Cramer declared, "The single biggest bull market is in the nonpharmaceutical health care sector," and he would buy Cigna.
Volcano (NasdaqGM: VOLC), Boston Scientific (NYSE: BSX - News), Johnson & Johnson (NYSE: JNJ - News), and General Electric (NYSE: GE - News)
A great way to play fears over drug-coated stents is to buy Volcano, a company that makes intravascular ultrasound catheters which examine the inside of arteries, according to Cramer. Although this technology is not new, it has been underused until the recent stent controversy. Volcano's largest rival is BSX, which Cramer calls "the Citigroup of healthcare" and Volcano has partnerships with JNJ and GE.

Beware of Tech: Oracle (NasdaqGS: ORCL), Microsoft (NasdaqGS: MSFT), EMC (NYSE: EMC - News), SanDisk (NasdaqGS: SNDK), Seagate (NYSE: STX - News), Western Digital (NYSE: WDC - News), Komag (NasdaqGS: KOMG), IBM (NYSE: IBM - News), Micron's (NYSE: MU - News), Texas Instruments (NYSE: TXN - News), Intel (NasdaqGS: INTC), Advanced Micro Devices (NYSE: AMD - News), Garmin (NasdaqGS: GRMN), Qualcomm (NasdaqGS: QCOM), Cisco (NasdaqGS: CSCO), Hewlett-Packard (NYSE: HPQ - News), eBay (NasdaqGS: EBAY), Apple (NasdaqGS: AAPL), Yahoo! (NasdaqGS: YHOO) and IAC/InterActive (NasdaqGS: IACI)
Cramer devoted his Sell Block segment to warning investors not to touch tech until summer, with a few notable exceptions. "Don't be bamboozled by hopeful analysts," he said, and added ORCL, MSFT, EMC, SNDK, STX, WDC, and KOMG are not buys right now. Cramer said IBM should not be bought until it has some "breakthrough earnings releases" and urged investors to ignore MU's upgrade and to avoid TXN, INTC and AMD. However, the few tech stocks worth buying now include GRMN, QCOM, CSCO and HPQ, EBAY, AAPL and YHOO. Cramer is removing IACI from his list of buys.
CEO Interview: David Snow, Medco Health Solutions (NYSE: MHS - News)
When Cramer asked David Snow how his company makes money off of drugs that go generic, he replied, "In the case of generics, $50 billion of branded drugs are going off patent between now and 2011. We are going to work very hard to appropriately move people from branded drugs to generic drugs, and we make money doing that." On the topic of Medco's cash flow, David Snow said the %5.5 billion buyback program is up and running, and the company might make a future acquisition. Cramer said Medco is the definition of a buy in the current environment.
Published By SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , ,

Thursday, January 25, 2007

Jim Cramer's Mad Money Lightning Round Jan. 24

Bullish calls:
Boeing (BA): ' ... it's two thumbs up, way up. That Wachovia guy who downgraded BA - he is going to be so massively wrong, it is frightening... 'Transocean (RIG): ' We like RIG.'Halliburton (HAL): ' ... yes, I'll stick my neck out once again, that HAL will be good.'NYSE (NYX): 'There's a story out there ... It says that there's going to be a massive lockup expiration, where everybody can sell 20 million shares. All the bears are keying on that ... my canvas of the stock tells me that none of the big holders is going to sell that stock. That's why NYX - which is my growth stock of the year - is headed to nothing short of $200!'Hain Celestial (HAIN): 'I would recommend HAIN as best of breed.'Level 3 Communications (LVLT): 'I say you should not be worried. This stock has had a miraculous run. But, it just again cleaned up its balance sheet even more by offering stock. This is one of my growth stocks that are speculative for the year. I reiterate my buy and, if it ever goes below $6, obviously you back up the truck!'Schering-Plough (SGP): 'I would vastly prefer SGP or JNJ [to PFE].'Johnson & Johnson (JNJ)Amgen (AMGN): 'I like AMGN and I like DNA for a little bit of growth.'Genentech (DNA)American Ecology (ECOL): ' ... look at ECOL.'Unilever (UN): 'I've been watching this stock creep up, and I keep saying to myself, 'Why didn't I recommend it? I knew that a turnaround was in place . I have missed UN. My bad. Is it too late to get in? No. Buy, buy, buy!'Diageo (DEO)Rackable Systems (RACK): 'I think it's way overdone to the downside ... I think you wait until the summer, you'll catch a bounce ... you stick with RACK. I don't want to go away from it.'eBay (EBAY)USG (USG): 'The only in-housing play that I've been recommending consistently is USG... I came back and said that stock is going higher. Swap out of yours and go into USG!'
Bearish calls:
Valero Energy (VLO): ' ... don't think VLO's going to do much. It's up 3 bucks, down 3 bucks... I'd like you to take the trade off though. I just don't think that, with oil and gas this low, that you really want to trifle with any of these things to buy on the way down, so let's ix-nay that trade when it comes in a little, and let's play on the long side.'SunOpta (STKL): 'We're swapping out of STKL and we're going into HAIN... 'Georgia Gulf (GGC): 'The only in-housing play that I've been recommending consistently is... Swap out of yours and go into USG!'Pfizer (PFE): 'You've got what I call dead money ... Keep selling PFE. It's just like owning a bond, but a little less exciting.'Republic Services (RSG): ' ... when we buy a company at twice its growth rate, in terms of a P/E, it's been catastrophic for us. So I want you to sell that one - sell, sell, sell.'
Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , , , ,

Bullish calls:
Boeing (BA): ' ... it's two thumbs up, way up. That Wachovia guy who downgraded BA - he is going to be so massively wrong, it is frightening... 'Transocean (RIG): ' We like RIG.'Halliburton (HAL): ' ... yes, I'll stick my neck out once again, that HAL will be good.'NYSE (NYX): 'There's a story out there ... It says that there's going to be a massive lockup expiration, where everybody can sell 20 million shares. All the bears are keying on that ... my canvas of the stock tells me that none of the big holders is going to sell that stock. That's why NYX - which is my growth stock of the year - is headed to nothing short of $200!'Hain Celestial (HAIN): 'I would recommend HAIN as best of breed.'Level 3 Communications (LVLT): 'I say you should not be worried. This stock has had a miraculous run. But, it just again cleaned up its balance sheet even more by offering stock. This is one of my growth stocks that are speculative for the year. I reiterate my buy and, if it ever goes below $6, obviously you back up the truck!'Schering-Plough (SGP): 'I would vastly prefer SGP or JNJ [to PFE].'Johnson & Johnson (JNJ)Amgen (AMGN): 'I like AMGN and I like DNA for a little bit of growth.'Genentech (DNA)American Ecology (ECOL): ' ... look at ECOL.'Unilever (UN): 'I've been watching this stock creep up, and I keep saying to myself, 'Why didn't I recommend it? I knew that a turnaround was in place . I have missed UN. My bad. Is it too late to get in? No. Buy, buy, buy!'Diageo (DEO)Rackable Systems (RACK): 'I think it's way overdone to the downside ... I think you wait until the summer, you'll catch a bounce ... you stick with RACK. I don't want to go away from it.'eBay (EBAY)USG (USG): 'The only in-housing play that I've been recommending consistently is USG... I came back and said that stock is going higher. Swap out of yours and go into USG!'
Bearish calls:
Valero Energy (VLO): ' ... don't think VLO's going to do much. It's up 3 bucks, down 3 bucks... I'd like you to take the trade off though. I just don't think that, with oil and gas this low, that you really want to trifle with any of these things to buy on the way down, so let's ix-nay that trade when it comes in a little, and let's play on the long side.'SunOpta (STKL): 'We're swapping out of STKL and we're going into HAIN... 'Georgia Gulf (GGC): 'The only in-housing play that I've been recommending consistently is... Swap out of yours and go into USG!'Pfizer (PFE): 'You've got what I call dead money ... Keep selling PFE. It's just like owning a bond, but a little less exciting.'Republic Services (RSG): ' ... when we buy a company at twice its growth rate, in terms of a P/E, it's been catastrophic for us. So I want you to sell that one - sell, sell, sell.'
Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , ,

Monday, January 15, 2007

Hot Stocks for 2007

Return to the Limelight
Jay Weinstein, of Oak Forest Investment Management, in Bethesda, Md., my guru for undervalued, ultra-small companies, in 2005 picked Atrion (ATRI), a medical-products company, and it jumped 57%. For 2006, he chose Astronics (ATRO), only one letter away, and it rose 60%. Now, for 2007, he's back to Atrion. "Chief executive Emile Battat and his chief financial officer, Jeff Strickland, have done a phenomenal job building shareholder value," Weinstein tells me. He sees Atrion ending 2007 with no debt and $6 a share in earnings. So at current prices you are paying a multiple of 13 times earnings -- puny for a company growing at better than 15% annually. Weinstein reveals that his clients own a big chunk of the stock. But with a market capitalization (shares outstanding times the stock price) of just $145 million, the share price is apt to be volatile.
Last year, I said Tom Brown "is probably the best financial-stock analyst in the business." After the performance of First Marblehead (FMD), which returned 152% (best on my list for 2006) and which, by the way, Brown still likes, I am going to drop the "probably." For the year ahead, one of the holdings of Brown's hedge fund jumps out: CompuCredit (CCRT). The company focuses on the subprime lending market, issuing credit cards, auto loans, and small "payday" advances to people without the best creditworthiness. CompuCredit is a smart operator in a tough business. "Earnings growth and profitability have been strong -- and figure to stay that way," writes Brown, but "CompuCredit's stock trades at an extremely low valuation" -- just eight times the $4.60 in earnings per share that Brown expects in 2007.
I have rhapsodized over Hennessy Cornerstone Growth, a mutual fund that follows a stock-picking formula that screens for rising earnings, a low price-to-sales ratio and above-average stock-price increases. The fund has returned an annualized 17% over the past five years. Its low price-to-sales criterion means that an abundance of retailers and energy companies qualify for the portfolio, so I prefer to look for stocks in other sectors. One of the best is Emcor Group (EME), which designs, operates and maintains sophisticated electrical and mechanical systems for factories, utilities and office buildings. The stock is pricey, but growth is impressive, with profits expected to rise by one-third in 2007.
A Health-care Pick
As I write this column, Fidelity Equity-Income fund is on track to beat the S&P 500 for the seventh year in a row, at risk levels well below the benchmark. Managed by Stephen Petersen for the past 13 years, the fund owns large-company stocks that pay nice dividends. Petersen is adding to the fund's holdings of Johnson & Johnson (JNJ), maker of drugs, medical devices and consumer health products. Although the business could be under the gun of a Democratic Congress, shares trade at a modest valuation of 16 times expected 2007 earnings, with a dividend that's rising at a consistent, double-digit rate.
Value Line Investment Survey has a great record for picking stocks. As of December 1, only two of the roughly 2,000 stocks that Value Line covers received top ratings for both timeliness and safety: Lockheed Martin and Du Pont. It's a tough choice, but I slightly prefer Lockheed Martin (LMT), the aerospace company. Its stock has doubled since early 2004 but still trades at a price-earnings ratio of 16, based on estimated 2007 earnings. Plus, its volatility is well below the market as a whole.
Magazines and More
I'm a fan of money manager Joel Greenblatt, author of The Little Book That Beats the Market, which sensibly advocates a stock-picking strategy that combines both growth and value elements. Greenblatt operates a free stock screener at www.magicformulainvesting.com. When I tried it last year, the screener produced 25 attractive selections, of which I picked American Eagle Outfitters. It returned a juicy 121%. Facing another 25 choices, I am drawn to Meredith (MDP), publisher of Better Homes & Gardens and other magazines and owner of 14 television stations. At a time when traditional media are out of favor, Meredith has been increasing its profits at a rapid pace. Nevertheless, it carries a modest valuation.
Ric Prentiss, the top telecom analyst at Raymond James & Associates, a brokerage with an exceptional track record for stock picking, tells me his best idea right now is a small company with an unwieldy name -- Ntelos (NTLS). It sells wireless phone and Internet service to customers in Virginia and West Virginia. Also, Ntelos sells wholesale wireless service to Sprint and, says Prentiss, it should benefit as Sprint moves its newly acquired Nextel customers to the CDMA technology that Ntelos provides. A big attraction of the stock, says Prentiss, is that it's cheap compared with similar businesses. Why? The company, founded in 1897, is "still not very well known." That's what we like in a stock: market inefficiency.
Friess Associates, which manages $12 billion in assets through vehicles such as the wonderful Brandywine fund, has kind words for SkyWest (SKYW), a regional airline that, in the words of the Friess newsletter, Looking Forward, "receives payment [from Delta and United] for each completed departure rather than on a percentage-of-revenue basis, minimizing the effects of load factors and fuel price hikes." Considering its rate of profit growth, the stock trades at a low valuation of nine times expected 2007 profits.
After two big losers in a row, the Prudent Speculator newsletter has been placed in my penalty box, and I'm returning to an old favorite among newsletters, Dow Theory Forecasts, for a selection. We need an energy company for 2007, and highly rated on the Dow Theory buy list is ConocoPhillips (COP), which has been rearranging its portfolio in a way that appears perspicacious. For example, Conoco's purchase of Burlington Resources in March 2006 made it the largest natural-gas producer in North America -- a smart move in a tight market. Based on expected 2007 earnings, shares trade at a P/E of just 8 and yield 2.1%.
Unloved and Little Known
Now, here's a contrarian stock. Universal Forest Products (UFPI) makes wood and plastic building products, such as roof trusses, for the construction and do-it-yourself sectors. With the decline in the housing market, the stock skidded 40% between May and December. It is, however, a selection of one of my favorite analysts, Cleveland-based Elliott Schlang, of Great Lakes Review, who focuses on midwestern stocks in boring industries. He likes companies with heavy insider ownership, strong cash flow and solid balance sheets. Universal meets the criteria and, trading at a P/E of 12 based on estimated 2007 earnings, it looks awfully cheap. That's the list. Just remember warning number three.
By James K. Glassman, Kiplinger's Personal Finance

Labels: , , , , , , , , , , ,

Tuesday, December 26, 2006

Jim Cramer's Mad Money Review

Four Dividend Gifts: U.S. Bancorp (NYSE: USB - News), National City (NYSE: NCC - News), Asbury Automotive (NYSE: ABG - News), and United Online (NASDAQ: UNTD - News)
Cramer listed four stocks that "keep on giving" with their great dividends. U.S. Bancorp has a 4.4% yield and a 35 year history of consistently raising its dividend, Cramer observes, adding that it has a good buyback program and a "pristine balance sheet." In addition to National City's 4.2% dividend and its "big fat buyback" Cramer applauds the company for getting rid of its low-margin mortgage business and setting up a position in Florida. ABG, which sells cars in the $30,000 to $35,000 range has good earnings growth, comments Cramer, and has the money to raise its 3.3% dividend. Finally, Cramer calls UNTD "the big one" with a 6.1% dividend and a "serious growth business."

Hot and Cool: Omniture (NASDAQ: OMTR - News), InnerWorkings (NASDAQ: INWK - News), Riverbed (NASDAQ: RVBD - News), DivX (NASDAQ: DIVX - News) and Acme Pocket (NASDAQ: APKT - News)
Last week, Cramer discussed "hot stocks" and said that OMTR, INWK and RVBD were not "too hot to buy," and are good for the next six to nine months, but on Friday he emphasized that he would sell DIVX. Cramer's fifth hot stock is APKT, which is a pioneer in the Internet telephony business and "hasn't even started to run yet." Cramer notes that it has reported good profits for four consecutive quarters, has "massive revenue growth" and, since it is covered by only five analysts, APKT has upgrade potential. Although those who hold the stock on the April 10th expiration of its share lockup will be hurting, Cramer assures investors that they have a few months to watch the stock rise and says ACME is "too cool not to handle, and it is far from being too hot."

Desperate Hedgies: Apple (NASDAQ: AAPL - News), Google (NASDAQ: GOOG - News), Goldman Sachs (NYSE: GS - News), Research In Motion (NASDAQ: RIMM - News), AIG (NYSE: AIG - News), Devon Energy (NYSE: DVN - News), Johnson & Johnson (NYSE: JNJ - News) and Halliburton (NYSE: HAL - News)
Hedge fund managers whose funds have not been doing well in the past year are frantically selling stocks such as APPL, GOOG and GS which are "symbolic of the market" to make it seem as if the performance of their funds is related to the health of the Dow. Instead of worrying, Cramer suggests investors use this "short-term, rumor-down market" to pick up some good quality stocks such as RIMM, AIG, DVN, JNJ and HAL at low prices; "After buying them on the cheap next week, take them in 2007 and enjoy it," he said.
CEO Interview: Bruce Williamson Dynegy (NYSE: DYN - News)
Bruce Williamson said that his company's deal with LS Power will increase assets under management by 70% and will add more cash flow. When asked how the deal will affect DYN's exposure to natural gas, Williamson replied, "With LS Power, it is going to to drop our exposure of a dollar move of natural gas down from 10% of EBITDA to a 4% move in EBITDA... It stabilizes the platform." Cramer applauded Williamson and called him a "winner."

Labels: , , , , , , , , , , , , , , , , , , ,